Document Type : Research Paper
Authors
1 National Center for Diabetes, AL-Mustansiriyah University - Iraq
2 Department of Applied Science, University of Technology - Iraq
Abstract
The most two common autoimmune disease in endocrinology was Diabetes mellitus (DM) and thyroid dysfunction (TD). This study aimed to investigate the prevalence of TD in DM patients of type 1. The current study is carried out in the National Center for Diabetes of Endocrine and Genetic (NCDEG), AL- Mustansiriyah University, Baghdad. This study comprised of (36) patients with hypothyroidism diagnosed clinically under supervision of specialist physician in endocrinology. Their ages ranged between (30-40) years, among them there were 17 males (48%) and 19 females (52%). In addition there were (36) healthy control their age ranged between (28-42) years, among them there were 21 males (58%) and 15 females (42%). Results showed highly significant increase in the rate of Chol, TSH, T3, and FBS in patient group when compared with healthy subject (p<0.001), also highly significant decrease of T4 (p<0.001). The prevalence of thyroid dysfunction among type 1 DM patients is very high with hypothyroidism is being most common. This study recommended that screening of thyroid function must be done especially in uncontrolled diabetic patients.
Keywords
Main Subjects
“Prevalence of thyroid dysfunction in patients with
diabetes mellitus,” Int J Res Med Sci.; Vol. 3, No. 12,
3629-3633, 2015.
[2] A. Khurana, P. Dhoat,and G.Jain “Prevalence of
thyroid disorders in patients of type 2 diabetes
mellitus,” JIACM; Vol. 17, No. 1, 12-15, 2016.
[3] E. McCanlies, A. O’ Leary, T. Foley, M. Kaye, and
P. Burke “Hashimoto’s Thyroiditis and InsulinDependent Diabetes Mellitus: Differences among
Individuals with and without Abnormal Thyroid
Function,” The Journal of Clinical Endocrinology &
Metabolism, Vol. 83, Issue 5, 1548–1551, 1998.
[4] C. Wang, “The Relationship between Type 2
Diabetes Mellitus and Related Thyroid Diseases,” J
Diabetes Res., Published online Apr 4 2013.
[5] J. Garber, R. Cobin, H. Gharib, and J. Hennessey,
“Clinical practice guidelines for hypothyroidism in
adults: cosponsored by the American Association of
Clinical Endocrinologists and the American Thyroid
Association,” Endocr Pract, Vol. 18, No. 6, 988-1028,
2012.
[6] P. Caturegli, A. De Remigis, and N.R. Rose,
“Hashimoto thyroiditis: Clinical and diagnostic
criteria,” Autoimmunity ReviewsVol. 13, Issues 4–5,
391-397, 2014.
[7] R. Abdulmahdi Mohsin, Thesis, “'Detection of
Prediabetes in Hypothyroidism Iraqi Patients,” 2014.
[8] P. Raghuwanshi, D. Pratap, and B. Kumar,
“Evaluation of thyroid dysfunction among type 2
diabetic patients,” Asian Journal of Medical Sciences,
Vol. 6, No. 3, 2015.
[9] R. Swamy, N. Kumar1, and K. Srinivasa,
“Evaluation of hypothyroidism as a complication in
Type II Diabetes Mellitus,” Biomedical Research; Vol.
23, No. 2, 170-172, 2012.
[10] V. Witting, D. Bergis, and D. Sadet, “Thyroid
disease in insulin-treated patients with type 2 diabetes:
a retrospective study,” Thyroid Res.; Vol. 7, No. 2,
2014.
[11] H. Abdi, E. Kazemian, S. Gharibzadeh, and A.
Amouzegar, “Association between Thyroid Function
and Body Mass Index: A 10-Year Follow-Up,” Ann
Nutr Metab, Vol. 70, No. 4, 338-345, 2017.
[12] N. Chary, K. Pindicura and D. Sreedhar,
“Developmental Anomalies of Thyroid Gland, FNAC
Based Study, In a Tertiary Care Hospital for Head and
Neck Diseases,” Sch. J. App. Med. Sci.; 4, 6A, 1936-
1939, 2016.
[13] D. Greef, J. Rondeel, and V. Haasteren,
“Regulation of hypothalamic TRH production and
release in the rat,” Acta Med Austriaca, 9 Suppl 1, 77-
9, 1992.
[14] National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK), “Hashimoto's Disease,”
article, 2017.
[15] F. Monaco, “Classification of Thyroid Diseases:
Suggestions for a Revision,” The Journal of Clinical
Endocrinology & Metabolism, Volume 88, Issue 4,
Pages 1428–1432, 2003.
[16] S. Mushtaq, S. Ishaq, and T. Rashid,
“DYSLIPIDEMIA IN THYROID DISORDERS,”
Indo American Journal of Pharmaceutical Research,
ISSN NO: 2231-6876, 2015.
[17] Q. Bayar, S. Arif, anhd A. Mohammed,
“Dyslipidemia in Subclinical Hypothyroidism: A
Case-Control Study,” J. Endocrinol Diab, 5, 1, 1-6.,
2018.
[18] G. Brenta, and O. Fretes, “Dyslipidemias and
hypothyroidism,” Pediatr Endocrinol Rev. Jun, 11, 4,
390-9, 2014.
[19] M. Peppa, G. Betsi, and G. Dimitriadis, “Lipid
Abnormalities and Cardiometabolic Risk in Patients
with Overt and Subclinical Thyroid Disease” Journal
of Lipids, Vol. Article ID 575840, 9 pages, 2011.
[20] G.A. Brent, “Mechanisms of thyroid hormone
action,” J Clin Invest. Sep 4; 122, 9, 3035–3043, 2012.
[21] Harvard Medical School,
http://www.health.harvard.edu/E, “Thyroid disease:
Understanding hypothyroidism and hyperthyroidism,”
2007.
)
